GreenLight Biosciences Inc

GRNA | $0.2995 -0.03% -0.07% 0

(0.0% 1d) (-0.0% 1m) (-8.2% 1y) (-0.0% 2d) (0.4% 3d) (0.0% 7d) (-73.35% volume)
Earnings Calendar:
Market Cap: $ 45,428,554

Sec Filling | Patents | 2022 employees

greenlight biosciences is a privately-held biotechnology company focused on sustainable production of chemicals and fuels using its patented cell free bioprocessing technology platform. this revolutionary technology enables the biological conversion of economical, renewable substrates to valuable products with unprecedented flexibility and control.

t-cell renewable

add to watch list Paper trade email alert is off

Light & Wonder Inc

LNW 4 | $88.11 -0.41% -0.41% 650K

Professional, Scientific, and T...

(0.0% 1d) (-13.8% 1m) (47.5% 1y) (0.0% 2d) (0.0% 3d) (-3.8% 7d) (-1.62% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 7,914,857,596
https://www.scientificgames.com
Sec Filling | Patents | 9000 employees

(US) Scientific Games Corporation is a world leader in entertainment offering dynamic games, systems and services for casino, lottery, social gaming, online gaming and sports betting. Scientific Games offers the gaming industry's broadest and most integrated portfolio of game content, advanced systems, cutting-edge platforms and professional services. Committed to responsible gaming, Scientific Games delivers what customers and players value most: trusted security, engaging entertainment content, operating efficiencies and innovative technology.

games pets security

add to watch list Paper trade email alert is off

MicroAlgo Inc

MLGO | $2.49 5.51% 5.22% 1.2M

Professional, Scientific, and T...

(0.0% 1d) (408.2% 1m) (10.3% 1y) (0.0% 2d) (0.0% 3d) (-4.8% 7d) (-60.08% volume)
Earnings Calendar:
Market Cap: $ 12,850,071

Sec Filling | Patents | n/a employees

add to watch list Paper trade email alert is off

Quince Therapeutics Inc

QNCX | $1.055 5.5% 5.21% 81K

Professional, Scientific, and T...

(0.0% 1d) (-13.0% 1m) (-34.2% 1y) (0.0% 2d) (0.0% 3d) (-0.5% 7d) (-64.75% volume)
Earnings Calendar: 2023-05-10
Market Cap: $ 45,592,071
https://www.cortexyme.com
Sec Filling | Patents | 38 employees

Cortexyme, Inc. is a clinical stage biopharmaceutical company pioneering upstream therapeutic approaches designed to improve the lives of patients diagnosed with Alzheimer's and other degenerative diseases. Based upon the evidence generated to date, Cortexyme is currently advancing its lead therapeutic candidate, atuzaginstat (COR388), in the GAIN Trial, an ongoing Phase 2/3 clinical trial in patients with mild to moderate Alzheimer's disease. Cortexyme is targeting a specific, infectious pathogen found in the brain and other organs and tied to degeneration and inflammation in humans and animal models.

animals alzheimer alzheimer’s pathogens

add to watch list Paper trade email alert is off

Dominari Holdings Inc

DOMH | $2.77 -1.07% -1.08% 11K

Professional, Scientific, and T...

(0.0% 1d) (20.3% 1m) (-26.1% 1y) (0.0% 2d) (0.0% 3d) (-5.1% 7d) (-56.1% volume)
Earnings Calendar:
Market Cap: $ 16,439,720
https://aikidopharma.com
Sec Filling | Patents | 5 employees

(US) AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, we are constantly seeking to grow our pipeline to treat unmet medical needs in oncology. The Company is also developing a broad-spectrum antiviral platform that may potentially inhibit replication of multiple viruses including Influenza virus, SARS-CoV (coronavirus), MERS-CoV, Ebolavirus and Marburg virus.

leukemia pancreatic cancer antiviral influenza education

add to watch list Paper trade email alert is off